Tryptamine derivatives active on central nervous system

Details Tryptamine derivatives active on central nervous system Tryptamine derivatives active on central nervous system

1988-03-30

1989-09-26

Brust, Joseph Paul

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514414, 546167, 546201, 548468, A61K 3140, A61K 31445, C07D20916, C07D21114

Patent

active

048700851

ABSTRACT:
Novel tryptamines of the formula ##STR1## in which X is an alkylene chain or 2 to 4 carbon atoms wherein a carbon atom may be replaced by O or N-lower alkyl, and wherein a carbon atoms may be substituted by lower alkyl,

REFERENCES:
patent: 3183235 (1965-05-01), Zenitz
patent: 3642803 (1972-02-01), Welstead, Jr.
patent: 3732248 (1973-05-01), Canas-Rodriguez et al.
patent: 3907812 (1975-09-01), Yamamato et al.
patent: 3953442 (1976-04-01), Demarne
patent: 4435410 (1984-03-01), LeFur et al.
patent: 4478841 (1984-10-01), Audiau et al.
C.A.; vol. 67, (1967); 89633n; Daleva, et al.,
C.A., vol. 94, (1981); 94:41139m; Guereny et al.
C.A., vol. 94, (1981); 94:47062c; Agarwal et al.,
C.A., vol. 91, (1979); 91:91438s; Fleming et al.
C.A., vol. 91, (1979); 91:168362x; Fukumori et al.

Affiliated with

Also associated with

Rating

Tryptamine derivatives active on central nervous system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tryptamine derivatives active on central nervous system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tryptamine derivatives active on central nervous system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-187942